drug
eflornithine hydrochloride
Marketedupdated 3mo agoby US WorldMeds LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 13, 2026
117 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Feb 12, 2036method-of-use (U-4444)US 12582625
FDA exclusivities (2)
- Dec 13, 2030ODE-462Orphan Drug (7y)4.3y
- Dec 13, 2026NPNP117d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that